CMV-specific immunotherapy

This publication has 35 references indexed in Scilit:

• Isolation and expansion of human cytomegalovirus- specific cytotoxic T lymphocytes using interferon-γ secretion assay
  Experimental Hematology, 2002
• Adenovirally Transduced Dendritic Cells Induce Bispecific Cytotoxic T Lymphocyte Responses Against Adenovirus and Cytomegalovirus pp65 or Against Adenovirus and Epstein-Barr Virus EBNA3C Protein: A Novel Approach for Immunotherapy
  Human Gene Therapy, 2002
• Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells
  Transplantation and Cellular Therapy, 2001
• A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects
  The Journal of Infectious Diseases, 2001
• Retroviral Transduction of a T Cell Receptor Specific for an Epstein–Barr Virus-Encoded Peptide
  Clinical Immunology, 2001
• Virus-specific CD8+ T-cell memory determined by clonal burst size
  Nature, 1994
• Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
  Science, 1992
• Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8⁺ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington
  Human Gene Therapy, 1992
• Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation
  New England Journal of Medicine, 1988
• Cytotoxic T Cells in Cytomegalovirus Infection
  New England Journal of Medicine, 1982